Minimal SN Tumor Burden

Active, not recruitingOBSERVATIONAL
Enrollment

296

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2031

Conditions
Cutaneous Melanoma
Trial Locations (22)

Unknown

U.Z. Leuven - Campus Gasthuisberg, Leuven

CHRU de Lille, Lille

CHU de Nice - Hopital De L'Archet, Nice

Institut Gustave Roussy, Paris

Charite - Universitaetsmedizin Berlin - Campus Mitte, Berlin

Universitaetsklinikum - Essen, Essen

UniversitaetsMedizin Mannheim, Mannheim

Istituto Europeo di Oncologia, Milan

Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Napoli

Istituto Oncologico Veneto IRCCS - Ospedale Busonera, Padua

The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam

Erasmus MC Cancer Institute - location Daniel den Hoed, Rotterdam

Maria Sklodowska-Curie Memorial Cancer Centre, Warsaw

The Institute Of Oncology, Ljubljana

Hospital Clinic Universitari, Barcelona

Centre Hospitalier Universitaire Vaudois, Lausanne

Royal Bournemouth Hospital, Bournemouth

Cambridge University Hospital NHS - Addenbrookes Hospital, Cambridge

Guy's and St Thomas' NHS - St Thomas Hospital, London

St George's Hospital NHS Trust, London

Norfolk And Norwich Hospital, Norwich

St Helens & Knowsley NHS Trust - Whiston Hospital, Prescott

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT01942603 - Minimal SN Tumor Burden | Biotech Hunter | Biotech Hunter